Compass Pathways PLC
NASDAQ:CMPS
Compass Pathways PLC
NASDAQ:CMPS
Price:
8.53 USD
3.39%
Market Closed
Updated:
May 6, 2024
Compass Pathways PLC
Cash from Financing Activities
|
Compass Pathways PLC
Cash from Financing Activities Peer Comparison
Comparables:
CNTA
AUTL
BCYC
IMCR
GNS
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Compass Pathways PLC
NASDAQ:CMPS
|
Cash from Financing Activities
$173.8m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Cash from Financing Activities
$21.1m
|
CAGR 3-Years
149%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Cash from Financing Activities
-$883k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Cash from Financing Activities
$250m
|
CAGR 3-Years
22%
|
CAGR 5-Years
58%
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Cash from Financing Activities
£34.3m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
221%
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
Cash from Financing Activities
-£20.5m
|
CAGR 3-Years
5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Compass Pathways PLC's Cash from Financing Activities?
Cash from Financing Activities
173.8m
USD
173.8m
USD
Based on the financial report for Dec 31, 2023, Compass Pathways PLC's Cash from Financing Activities amounts to 173.8m USD.
What is Compass Pathways PLC's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
39%
39%
Over the last year, the Cash from Financing Activities growth was 16 614%. The average annual Cash from Financing Activities growth rates for Compass Pathways PLC have been -4% over the past three years , 39% over the past five years .
You don't have any saved screeners yet
